SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001062993-24-003282
Filing Date
2024-02-15
Accepted
2024-02-15 15:12:47
Documents
72
Period of Report
2023-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K/A form6ka.htm   iXBRL 6-K/A 28937
2 EXHIBIT 99.2 exhibit99-2.htm   iXBRL EX-99.2 1787122
8 GRAPHIC exhibit99-2xz001.jpg GRAPHIC 10242
  Complete submission text file 0001062993-24-003282.txt   9151743

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ipa-20231031.xsd EX-101.SCH 105108
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ipa-20231031_cal.xml EX-101.CAL 46742
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ipa-20231031_def.xml EX-101.DEF 164819
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ipa-20231031_lab.xml EX-101.LAB 1139117
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ipa-20231031_pre.xml EX-101.PRE 301011
74 EXTRACTED XBRL INSTANCE DOCUMENT form6ka_htm.xml XML 2177428
Mailing Address 880 - 580 HORNBY STREET VANCOUVER A1 V6C3B6
Business Address 880 - 580 HORNBY STREET VANCOUVER A1 V6C3B6 6048060626
ImmunoPrecise Antibodies Ltd. (Filer) CIK: 0001715925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: 6-K/A | Act: 34 | File No.: 001-39530 | Film No.: 24643456
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)